Evidence map›Paper›PMID 42248460›Full record

ArticleThe Journal of biological chemistry2026

Leucyl-tRNA synthetase as a molecular target of isobutanol-mediated growth inhibition in Saccharomyces cerevisiae.

Mano Hasegawa, Nodoka Oshimura, Kaho Hitomi, Ayako Furukawa, Kenji Sugase, Kouichi Kuroda

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mano HasegawaDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Nodoka OshimuraDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Kaho HitomiFaculty of Agriculture, Department of Applied Life Sciences, Kyoto University, Kyoto, Japan.
Ayako FurukawaDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Kenji SugaseDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. Electronic address: sugase.kenji.8c@kyoto-u.ac.jp.
Kouichi KurodaFaculty of Molecular Chemistry and Engineering, Graduate School of Science and Technology, Kyoto Institute of Technology, Kyoto, Japan. Electronic address: kuroda@kit.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our dependence on fossil fuels and ongoing environmental degradation urgently require sustainable energy solutions. Biofuels that do not rely on fossil resources have attracted significant scientific interest. Among these, isobutanol produced by yeast is a promising next-generation biofuel owing to its high-energy density and compatibility with existing fuel infrastructure. However, the inherently low tolerance of yeast to isobutanol constrains its production, posing a major barrier to the large-scale implementation of bio-based isobutanol. Here, we provide compelling evidence that supplementation with excess branched-chain amino acids (BCAAs), particularly leucine, alleviates isobutanol-induced growth inhibition in yeast. Using saturation transfer difference nuclear magnetic resonance (STD-NMR) spectroscopy and structural modeling, we showed that isobutanol directly interacts with cytoplasmic leucyl-tRNA synthetase (LeuRS), acting as a competitive inhibitor of leucine binding. Collectively, these findings reveal a mechanistic basis by which isobutanol inhibits yeast growth, offering new insights into enhancing isobutanol tolerance and production in yeast.

Indexed as

ButanolsLeucine-tRNA LigaseSaccharomyces cerevisiaeModels, MolecularButanolsisobutyl alcoholLeucine-tRNA LigaseBCAAscompetitive inhibitionisobutanolleucyl-tRNA synthetaseNMRSaccharomyces cerevisiae

Identifiers

PMID42248460
PMCPMC13355185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.